Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Obermann

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Therapeutic Advances in Neurological Disorders|November 25, 2015
An update on the management of post-traumatic headacheMark Obermann, Steffen Naegel, Bert Bosche, et al.
Current Pain and Headache Reports|April 2, 2011
Headache attributable to nonvascular intracranial disordersMark Obermann, Dagny Holle, Steffen Naegel, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 29, 2021
Bell's palsy following COVID-19 vaccination with high CSF antibody responseMark Obermann, Maliqe Krasniqi, Nadja Ewers, et al.
Cephalalgia : an International Journal of Headache|September 26, 2017
Remission of chronic headache: Rates, potential predictors and the role of medication, follow-up results of the German Headache Consortium (GHC) StudyVerena Henning, Zaza Katsarava, Mark Obermann, et al.
Cephalalgia : an International Journal of Headache|May 22, 2014
Vestibular migraineBenjamin Stolte, Dagny Holle, Steffen Naegel, et al.
Expert Opinion on Pharmacotherapy|April 26, 2015
Pharmacotherapy options for cluster headacheMark Obermann, Dagny Holle, Steffen Naegel, et al.
Trials|March 17, 2019
Upper limb strength training in subacute stroke patients: study protocol of a randomised controlled trialSusan Högg, Manfred Holzgraefe, Insa Wingendorf, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2016
Simultaneous early-onset immune thrombocytopenia and autoimmune thyroid disease following alemtuzumab treatment in relapsing-remitting multiple sclerosisMark Obermann, Tobias Ruck, Steffen Pfeuffer, et al.
BMC Neurology|July 30, 2013
Study protocol of Prednisone in episodic Cluster Headache (PredCH): a randomized, double-blind, placebo-controlled parallel group trial to evaluate the efficacy and safety of oral prednisone as an add-on therapy in the prophylactic treatment of episodic cluster headache with verapamilDagny Holle, Jan Burmeister, André Scherag, et al.
Trials|December 5, 2015
Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trialJan Burmeister, Dagny Holle, Eva Bock, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Therapeutic Advances in Neurological Disorders|November 25, 2015
An update on the management of post-traumatic headacheMark Obermann, Steffen Naegel, Bert Bosche, et al.
Current Pain and Headache Reports|April 2, 2011
Headache attributable to nonvascular intracranial disordersMark Obermann, Dagny Holle, Steffen Naegel, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 29, 2021
Bell's palsy following COVID-19 vaccination with high CSF antibody responseMark Obermann, Maliqe Krasniqi, Nadja Ewers, et al.
Cephalalgia : an International Journal of Headache|September 26, 2017
Remission of chronic headache: Rates, potential predictors and the role of medication, follow-up results of the German Headache Consortium (GHC) StudyVerena Henning, Zaza Katsarava, Mark Obermann, et al.
Cephalalgia : an International Journal of Headache|May 22, 2014
Vestibular migraineBenjamin Stolte, Dagny Holle, Steffen Naegel, et al.
Expert Opinion on Pharmacotherapy|April 26, 2015
Pharmacotherapy options for cluster headacheMark Obermann, Dagny Holle, Steffen Naegel, et al.
Trials|March 17, 2019
Upper limb strength training in subacute stroke patients: study protocol of a randomised controlled trialSusan Högg, Manfred Holzgraefe, Insa Wingendorf, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2016
Simultaneous early-onset immune thrombocytopenia and autoimmune thyroid disease following alemtuzumab treatment in relapsing-remitting multiple sclerosisMark Obermann, Tobias Ruck, Steffen Pfeuffer, et al.
BMC Neurology|July 30, 2013
Study protocol of Prednisone in episodic Cluster Headache (PredCH): a randomized, double-blind, placebo-controlled parallel group trial to evaluate the efficacy and safety of oral prednisone as an add-on therapy in the prophylactic treatment of episodic cluster headache with verapamilDagny Holle, Jan Burmeister, André Scherag, et al.
Trials|December 5, 2015
Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trialJan Burmeister, Dagny Holle, Eva Bock, et al.
Pageof 12